Lineage Cell Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC | 08/14/2026 | 49.56 M | $64.92 M | 0.00% | 19.86% |
| BLACKROCK, INC. | 08/07/2026 | 13.19 M | $17.27 M | 241.21% | 5.29% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 9.05 M | $11.86 M | 8.85% | 3.63% |
| DEFENDER CAPITAL, LLC. | 07/09/2026 | 6.60 M | $8.64 M | -1.94% | 2.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 5.30 M | $6.94 M | 110.04% | 2.12% |
| RAFFLES ASSOCIATES LP | 08/17/2026 | 5.20 M | $6.81 M | -3.08% | 2.08% |
| FIFTH THIRD BANCORP | 08/05/2026 | 4.60 M | $6.03 M | 0.00% | 1.84% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 3.02 M | $3.95 M | -45.72% | 1.21% |
| STATE STREET CORP | 08/07/2026 | 2.31 M | $3.03 M | 112.29% | 0.93% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 1.67 M | $2.19 M | 26.01% | 0.67% |
| NORTHERN TRUST CORP | 08/13/2026 | 1.66 M | $2.17 M | 231.91% | 0.66% |
| MORGAN STANLEY | 08/13/2026 | 1.47 M | $1.93 M | -21.25% | 0.59% |
| RENAISSANCE TECHNOLOGIES LLC | 08/13/2026 | 1.34 M | $1.76 M | -36.72% | 0.54% |
| MARSHALL WACE, LLP | 08/13/2026 | 1.28 M | $1.68 M | -58.16% | 0.51% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 1.27 M | $1.67 M | 100.00% | 0.51% |
| UBS GROUP AG | 08/13/2026 | 687.05 K | $900.04 K | -49.87% | 0.28% |
| RED CRANE WEALTH MANAGEMENT, LLC | 07/29/2026 | 597.26 K | $782.42 K | 0.00% | 0.24% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 577.44 K | $756.44 K | 344.44% | 0.23% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 577.44 K | $756.44 K | 100.00% | 0.23% |
| BARCLAYS PLC | 08/14/2026 | 508.67 K | $666.35 K | 29.33% | 0.20% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 444.77 K | $582.65 K | 210.62% | 0.18% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 433.27 K | $567.58 K | -62.95% | 0.17% |
| CITADEL ADVISORS LLC | 09/02/2026 | 426.17 K | $558.28 K | 225.45% | 0.17% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 424.37 K | $555.93 K | 1.20% | 0.17% |
| BANK OF NEW YORK MELLON CORP | 08/06/2026 | 391.68 K | $513.09 K | 1,587.31% | 0.16% |
| FLPUTNAM INVESTMENT MANAGEMENT CO | 08/06/2026 | 304.56 K | $398.98 K | 100.00% | 0.12% |
| NUVEEN, LLC | 08/11/2026 | 245.38 K | $321.45 K | 100.00% | 0.10% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 08/14/2026 | 221.00 K | $289.51 K | 0.00% | 0.09% |
| ASTER CAPITAL MANAGEMENT (DIFC) LTD | 08/13/2026 | 218.24 K | $198.03 K | 100.00% | 0.09% |
| MCMILLAN OFFICE, INC. | 08/13/2026 | 216.00 K | $282.96 K | 0.00% | 0.09% |
| FMR LLC | 08/13/2026 | 192.93 K | $252.73 K | -0.20% | 0.08% |
| DEUTSCHE BANK AG\ | 08/07/2026 | 183.32 K | $240.15 K | 100.00% | 0.07% |
| WELLS FARGO & COMPANY/MN | 08/14/2026 | 183.12 K | $239.88 K | 920.89% | 0.07% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 151.23 K | $199.00 K | 100.00% | 0.06% |
| RAYMOND JAMES FINANCIAL INC | 08/14/2026 | 148.29 K | $194.26 K | 76.57% | 0.06% |
| RHUMBLINE ADVISERS | 08/12/2026 | 129.54 K | $169.68 K | 100.00% | 0.05% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 08/14/2026 | 110.30 K | $144.49 K | 100.00% | 0.04% |
| COMMONWEALTH EQUITY SERVICES, LLC | 07/29/2026 | 102.18 K | $133.85 K | -0.63% | 0.04% |
| WILLIAMS JONES WEALTH MANAGEMENT, LLC. | 08/05/2026 | 101.30 K | $132.70 K | 0.00% | 0.04% |
| INVESCO LTD. | 08/14/2026 | 100.13 K | $131.17 K | 100.00% | 0.04% |
| HIGHTOWER ADVISORS, LLC | 08/05/2026 | 99.87 K | $130.83 K | 0.00% | 0.04% |
| CITIGROUP INC | 08/03/2026 | 86.60 K | $113.45 K | -50.53% | 0.03% |
| JPMORGAN CHASE & CO | 08/12/2026 | 86.53 K | $116.81 K | 690.63% | 0.03% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 85.80 K | $112.39 K | 0.00% | 0.03% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 08/14/2026 | 84.86 K | $111.16 K | 100.00% | 0.03% |
| TRUST CO OF TOLEDO NA /OH/ | 07/16/2026 | 83.80 K | $109.77 K | 0.00% | 0.03% |
| WEALTHSPIRE ADVISORS, LLC | 08/11/2026 | 80.09 K | $104.92 K | 100.00% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 63.40 K | $83.05 K | -20.55% | 0.03% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 08/14/2026 | 62.43 K | $81.78 K | -95.22% | 0.03% |
| XTX TOPCO LTD | 08/14/2026 | 58.37 K | $76.46 K | 80.32% | 0.02% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Lineage Cell Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 198 institutional investors and hedge funds held shares of Lineage Cell Therapeutics Inc. The most heavily invested institutionals were:
BROADWOOD CAPITAL INC: 49.56 M
BlackRock, Inc.: 13.19 M
VANGUARD CAPITAL MANAGEMENT LLC: 9.05 M
Defender Capital, LLC.: 6.6 M
GEODE CAPITAL MANAGEMENT, LLC: 5.3 M
RAFFLES ASSOCIATES LP: 5.2 M
47.02% of Lineage Cell Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 142.26 M shares in the last 24 months. This purchase volume represents approximately $250.38 M in transactions.